← Open Payments lookup

LUCAS MEREDITH: Open Payments

NPI 1841902053 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,015 in 136 payments from 23 companies in 2025. Trend: 2023 $896 · 2024 $3,378 · 2025 $8,015

Food & beverage: $3,635Consulting: $2,714Travel & lodging: $1,666
CompanyPaymentsAmount
BioCryst Pharmaceuticals, Inc.13$4,687
GENZYME CORPORATION17$531
AstraZeneca Pharmaceuticals LP22$512
Regeneron Healthcare Solutions, Inc.15$287
Novartis Pharmaceuticals Corporation12$282
Blueprint Medicines Corporation4$199
Ionis Pharmaceuticals, Inc.3$196
LEO Pharma Inc.3$153
Genentech USA, Inc.2$141
GlaxoSmithKline, LLC.12$140

Products named: ORLADEYO, DUPIXENT, AIRSUPRA, AYVAKIT, XOLAIR, Rhapsido, TEZSPIRE, DAWNZERA.

Industry payments across WA — which companies pay providers there.